Creative Planning’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
3,223
-14,175
| -81% | -$909K | ﹤0.01% | 3184 |
|
|
2025
Q1 | $1.1M | Buy |
+17,398
| New | +$1.1M | ﹤0.01% | 1638 |
|
|
2023
Q4 | – | Sell |
-300
| Closed | -$17.1K | – | 2932 |
|
|
2023
Q3 | $17.1K | Buy |
+300
| New | +$17.1K | ﹤0.01% | 2574 |
|
|
2022
Q2 | – | Sell |
-300
| Closed | -$19K | – | 2353 |
|
|
2022
Q1 | $19K | Buy |
+300
| New | +$19K | ﹤0.01% | 2117 |
|
|
2017
Q3 | – | Sell |
-1,700
| Closed | -$78K | – | 3077 |
|
|
2017
Q2 | $78K | Buy |
1,700
+990
| +139% | +$45.4K | ﹤0.01% | 2156 |
|
|
2017
Q1 | $30K | Sell |
710
-19,000
| -96% | -$803K | ﹤0.01% | 2815 |
|
|
2016
Q4 | $765K | Buy |
19,710
+19,005
| +2,696% | +$738K | ﹤0.01% | 732 |
|
|
2016
Q3 | $30K | Buy |
705
+205
| +41% | +$8.72K | ﹤0.01% | 2713 |
|
|
2016
Q2 | $18K | Sell |
500
-400
| -44% | -$14.4K | ﹤0.01% | 2843 |
|
|
2016
Q1 | $34K | Hold |
900
| – | – | ﹤0.01% | 2358 |
|
|
2015
Q4 | $45K | Buy |
900
+700
| +350% | +$35K | ﹤0.01% | 2170 |
|
|
2015
Q3 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 3237 |
|
|
2015
Q2 | – | Sell |
-200
| Closed | -$11K | – | 2321 |
|
|
2015
Q1 | $11K | Sell |
200
-400
| -67% | -$22K | ﹤0.01% | 3096 |
|
|
2014
Q4 | $30K | Buy |
600
+400
| +200% | +$20K | ﹤0.01% | 2329 |
|
|
2014
Q3 | $9K | Sell |
200
-1,000
| -83% | -$45K | ﹤0.01% | 2959 |
|
|
2014
Q2 | $52K | Buy |
1,200
+1,000
| +500% | +$43.3K | ﹤0.01% | 1846 |
|
|
2014
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 2808 |
|
|
2013
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 2722 |
|
|
2013
Q3 | $7K | Sell |
200
-200
| -50% | -$7K | ﹤0.01% | 2621 |
|
|
2013
Q2 | $12K | Buy |
+400
| New | +$12K | ﹤0.01% | 2184 |
|